ALFA FinderBSE filing, BSE: 544365. Summary written from the filing by ALFA Finder's alert engine.
Shanmuga Hospital Ltd: key numbers
- Share price
- ₹45.00
- Market cap
- ₹61.26 Cr
- Revenue (annual)
- ₹47.44 Cr
- Net profit (annual)
- ₹4.21 Cr
- P/E (TTM)
- 14.6×Sector 53.9×
- Promoter holding
- 72.35%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shanmuga Hospital Ltd
All →Shanmuga Hospital Board Meeting Date
Shanmuga Hospital Limited will hold a board meeting on 12 November 2026 to consider unaudited standalone half-year results for September 2026 and an interim dividend. Trading window closes from 1 October 2026.
Shanmuga Hospital Product Launch
Shanmuga Hospital commercially launched its 'Shanmuga 360' healthcare mobile app on 20 October 2026. It offers medicine booking, lab tests, ambulance and home-care services.
Shanmuga Hospital Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory norms.
Shanmuga Hospital Capital Structure Change
Shanmuga Hospital's members approved an increase in authorized share capital from ₹14 Crore to ₹25 Crore at the 6th Annual General Meeting.
Shanmuga Hospital Other Announcement
Shanmuga Hospital Limited appointed CS S Anuradha as the Secretarial Auditor for a five-year term starting from FY 2026-27.
- Execution
- 5 years (FY 2026-27 to FY 2030-31)
Shanmuga Hospital Management Change
Shanmuga Hospital Limited has appointed Mrs. S Anuradha as the new Secretarial Auditor. The appointment is for a term of 60 months.
Other annual report announcements
All →Generic Engineering Construction and Projects Annual Report
Generic Engineering filed its FY2025-26 Annual Report ahead of its 32nd AGM on 30 November 2026. The filing covers board changes and a planned bank-funded EPC expansion.
Vineet Laboratories Annual Report
Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.
Indrayani Biotech Annual Report
Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.
ESDS Software Solution Annual Report
ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.
The Orissa Minerals Development Company Annual Report
Orissa Minerals Development Company filed its FY 2025-26 Annual Report and 108th AGM notice, with the AGM set for 30 November 2026. The filing is a Regulation 34 intimation with no transaction or financial event.
Viksit Engineering Annual Report
Viksit Engineering filed its 44th Annual Report for FY 2025-26 with BSE. The report includes notice of the AGM on 30 November 2026.